ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 879 filers reported holding ISHARES TR in Q2 2024. The put-call ratio across all filers is 4.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,045,592 | -2.8% | 29,474 | -2.8% | 0.29% | -5.2% |
Q1 2024 | $4,160,914 | -0.7% | 30,323 | -1.7% | 0.30% | -7.0% |
Q4 2023 | $4,189,173 | +10.5% | 30,837 | -0.5% | 0.33% | -9.9% |
Q3 2023 | $3,790,049 | -6.6% | 30,992 | -3.0% | 0.36% | -37.1% |
Q2 2023 | $4,056,664 | -2.5% | 31,952 | -0.8% | 0.58% | -4.8% |
Q1 2023 | $4,160,152 | -9.4% | 32,209 | -7.9% | 0.61% | -9.1% |
Q4 2022 | $4,592,681 | +9.2% | 34,981 | -2.7% | 0.67% | -2.6% |
Q3 2022 | $4,204,000 | -0.3% | 35,942 | +0.3% | 0.69% | +6.7% |
Q2 2022 | $4,216,000 | -12.5% | 35,839 | -3.0% | 0.64% | 0.0% |
Q1 2022 | $4,816,000 | -15.3% | 36,960 | -0.8% | 0.64% | -11.8% |
Q4 2021 | $5,684,000 | -6.2% | 37,244 | -0.6% | 0.73% | -13.2% |
Q3 2021 | $6,057,000 | -2.0% | 37,468 | -0.8% | 0.84% | -1.1% |
Q2 2021 | $6,181,000 | +7.8% | 37,770 | -0.8% | 0.85% | +3.2% |
Q1 2021 | $5,733,000 | -0.5% | 38,076 | +0.1% | 0.82% | -5.9% |
Q4 2020 | $5,762,000 | +13.4% | 38,034 | +1.4% | 0.88% | +3.7% |
Q3 2020 | $5,079,000 | -1.5% | 37,515 | -0.5% | 0.84% | -8.1% |
Q2 2020 | $5,155,000 | +25.7% | 37,709 | -0.9% | 0.92% | +9.7% |
Q1 2020 | $4,101,000 | -8.8% | 38,066 | +2.1% | 0.84% | +18.5% |
Q4 2019 | $4,495,000 | +25.1% | 37,298 | +3.3% | 0.71% | +12.4% |
Q3 2019 | $3,592,000 | -12.8% | 36,096 | -4.4% | 0.63% | -14.7% |
Q2 2019 | $4,118,000 | -4.8% | 37,740 | -2.5% | 0.74% | -6.5% |
Q1 2019 | $4,326,000 | +11.4% | 38,694 | -3.9% | 0.79% | +25.7% |
Q4 2018 | $3,882,000 | -27.2% | 40,260 | -7.9% | 0.63% | -27.3% |
Q3 2018 | $5,332,000 | -6.0% | 43,726 | -15.4% | 0.86% | -15.1% |
Q2 2018 | $5,673,000 | -28.4% | 51,658 | -30.4% | 1.02% | -21.7% |
Q1 2018 | $7,924,000 | -2.4% | 74,230 | -2.4% | 1.30% | +1.3% |
Q4 2017 | $8,123,000 | -5.0% | 76,080 | +196.9% | 1.28% | -6.3% |
Q3 2017 | $8,548,000 | +4.1% | 25,624 | -3.3% | 1.37% | +2.1% |
Q2 2017 | $8,214,000 | +0.1% | 26,491 | -5.4% | 1.34% | -1.8% |
Q1 2017 | $8,209,000 | +10.1% | 27,990 | -0.4% | 1.36% | +6.2% |
Q4 2016 | $7,457,000 | -10.2% | 28,101 | -2.1% | 1.28% | -11.3% |
Q3 2016 | $8,308,000 | +10.9% | 28,701 | -1.4% | 1.45% | +10.6% |
Q2 2016 | $7,491,000 | -0.8% | 29,111 | +0.5% | 1.31% | -1.5% |
Q1 2016 | $7,555,000 | -24.4% | 28,965 | -2.0% | 1.33% | -25.7% |
Q4 2015 | $9,996,000 | +8.6% | 29,544 | -2.6% | 1.79% | +4.1% |
Q3 2015 | $9,203,000 | -29.9% | 30,339 | -14.7% | 1.72% | -19.8% |
Q2 2015 | $13,123,000 | +5.7% | 35,565 | -1.6% | 2.14% | +8.2% |
Q1 2015 | $12,413,000 | +12.0% | 36,143 | -1.0% | 1.98% | +14.1% |
Q4 2014 | $11,080,000 | +8.8% | 36,525 | -1.9% | 1.74% | +6.2% |
Q3 2014 | $10,184,000 | -1.2% | 37,218 | -7.2% | 1.63% | +4.5% |
Q2 2014 | $10,311,000 | -4.3% | 40,117 | -12.0% | 1.56% | -0.1% |
Q1 2014 | $10,779,000 | +1.1% | 45,594 | -2.9% | 1.56% | +2.6% |
Q4 2013 | $10,657,000 | +5.1% | 46,933 | -3.0% | 1.53% | +1.0% |
Q3 2013 | $10,140,000 | +13.3% | 48,382 | -6.0% | 1.51% | +12.4% |
Q2 2013 | $8,953,000 | – | 51,486 | – | 1.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |